Premium Nahrungsergänzungsmittel | artgerecht

Tesofensine-Peptide Stack: Effects, Risks and Use

The tesofensine-peptide stack combines the compound tesofensine with various peptides for weight loss. Learn about its mechanism of action, application, and safety profile.

Regular tips about health Regular tips about health

Things worth knowing about "Tesofensine-Peptide Stack"

The tesofensine-peptide stack combines the compound tesofensine with various peptides for weight loss. Learn about its mechanism of action, application, and safety profile.

What Is the Tesofensine-Peptide Stack?

The tesofensine-peptide stack refers to the combined use of tesofensine – an experimental triple monoamine reuptake inhibitor – with one or more peptides that target metabolism, appetite regulation, or body composition. This combination is primarily discussed in the context of weight optimization and bodybuilding, but remains largely experimental and is not officially approved in most countries.

Peptides such as semaglutide, CJC-1295, ipamorelin, or BPC-157 are frequently mentioned in such stacks, as they can act on appetite, fat metabolism, and muscle preservation through distinct mechanisms. The simultaneous use is intended to produce synergistic effects.

Mechanism of Action

Tesofensine

Tesofensine is a presynaptic inhibitor of the reuptake of serotonin, dopamine, and noradrenaline (triple monoamine reuptake inhibitor). This leads to reduced appetite and caloric intake, while potentially increasing energy expenditure. In Phase II clinical trials, tesofensine demonstrated significant weight reductions in obese patients.

Peptides in the Stack

Depending on the selection, the peptides included in the stack can serve different roles:

GLP-1 receptor agonists (e.g., semaglutide): Regulate blood sugar, slow gastric emptying, and reduce hunger signals.
Growth hormone-releasing peptides (e.g., CJC-1295, ipamorelin): Stimulate the body to release its own growth hormone, potentially supporting fat loss and muscle preservation.
BPC-157 (Body Protection Compound): A synthetic peptide discussed for its potential regenerative properties, including tissue repair and anti-inflammatory effects.
AOD-9604: A fragment of growth hormone designed to target fat metabolism without fully activating the growth hormone axis.

Application and Dosage

Because the tesofensine-peptide stack is neither regulated nor officially approved in most countries, no standardized dosage guidelines exist. In clinical studies, tesofensine was administered orally at doses of 0.25 mg to 1.0 mg per day. Peptides are typically injected subcutaneously, with dosages varying widely depending on the specific compound.

Important note: Self-administering this stack without medical supervision carries significant health risks. Medical oversight is strongly recommended.

Potential Benefits (Based on Experimental Reports)

Enhanced weight loss through synergistic mechanisms of action
Improved body composition (fat loss with muscle preservation)
Appetite suppression via multiple signaling pathways
Potential improvement in metabolic function and insulin sensitivity

Side Effects and Risks

Combining multiple unapproved substances carries substantial risks. Known or potential side effects include:

Cardiovascular effects: Elevated blood pressure and increased heart rate (due to the adrenergic activity of tesofensine)
Central nervous system effects: Insomnia, irritability, anxiety, and mood fluctuations
Gastrointestinal complaints: Nausea, vomiting, and diarrhea (particularly with GLP-1 peptides)
Injection site reactions: Redness, swelling, and pain with subcutaneous peptides
Endocrine disruption: Alterations in the hormonal axis with long-term use of growth hormone peptides
Unknown long-term risks due to the absence of long-term studies for the combination

Legal and Regulatory Classification

Tesofensine has not received market authorization as a medicinal product in the EU, the United States, or most other countries. It remains under clinical development. Most peptides commonly included in the stack are also not approved as human medicines or are available only under strict conditions. The purchase, possession, or use of these substances may have legal consequences depending on national law.

References

Astrup A. et al. - Tesofensine, a Novel Potent Weight Loss Medicine: A Randomized Controlled Trial - The Lancet (2008)
Friedrichsen M. et al. - The effect of tesofensine on appetite, energy intake and body weight - International Journal of Obesity (2016)
Drucker D.J. - The biology of incretin hormones - Cell Metabolism (2006)

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.